High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors

被引:197
作者
Gonzalez-Juanatey, Carlos
Llorca, Javier
Amigo-Diaz, Encarnacion
Dierssen, Trinidad
Martin, Javier
Gonzalez-Gay, Miguel A. [1 ]
机构
[1] Hosp Xeral Calde, Div Rheumatol, Lugo 27004, Spain
[2] Univ Cantabria, Sch Med, E-39005 Santander, Spain
[3] Consejo Super Invest Cient, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain
来源
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH | 2007年 / 57卷 / 06期
关键词
psoriatic arthritis; cardiovascular disease; atherosclerosis; carotid intima-media thickness; carotid plaques;
D O I
10.1002/art.22884
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the presence of subclinical atherosclerosis in patients with psoriatic arthritis (PsA) without clinically evident atherosclerosis or its complications, and to assess whether demographic or clinical factors affect the development of atherosclerotic disease in a series of patients with PsA attended to in a community hospital. Methods. Fifty-nine patients with PsA who fulfilled the Moll and Wright criteria were recruited from Hospital Xeral-Calde (Lugo, Spain). Patients seen during the period of recruitment who had classic cardiovascular risk factors or had experienced cardiovascular or cerebrovascular events were excluded. Fifty-nine healthy matched controls were also studied. Carotid artery intima-media thickness (IMT) and carotid plaques were measured in the right common carotid artery. The study was performed using high-resolution B-mode ultrasound. Results. Patients with PsA exhibited greater carotid artery IMT than did matched controls (mean +/- SD 0.699 +/- 0.165 mm versus 0.643 +/- 0.111 mm; P = 0.031; difference of means 0.056; 95% confidence interval 0.005-0.108). Adjusted for age, the carotid IMT was correlated with age at the time of PsA diagnosis (partial correlation coefficient [r] = -0.264, P = 0.04), disease duration (r = -0.264, P = 0.04), total cholesterol (r = 0.233, P = 0.01), and low-density lipoprotein cholesterol (r = 0.243, P = 0.01). Conclusion. The present study demonstrates that patients with PsA without cardiovascular risk factors or clinically evident cardiovascular disease have a high prevalence of macrovascular disease in the form of increased carotid artery IMT compared with ethnically matched controls.
引用
收藏
页码:1074 / 1080
页数:7
相关论文
共 44 条
[1]   Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein [J].
Beckman, JA ;
Liao, JK ;
Hurley, S ;
Garrett, LA ;
Chui, DS ;
Mitra, D ;
Creager, MA .
CIRCULATION RESEARCH, 2004, 95 (02) :217-223
[2]   Common carotid intima media thickness as an indicator of atherosclerosis at other sites of the carotid artery - The Rotterdam study [J].
Bots, ML ;
Hofman, A ;
deJong, PTVM ;
Grobbee, DE .
ANNALS OF EPIDEMIOLOGY, 1996, 6 (02) :147-153
[3]   Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension [J].
Brunner, H ;
Cockcroft, JR ;
Deanfield, J ;
Donald, A ;
Ferrannini, E ;
Halcox, J ;
Kiowski, W ;
Luscher, TF ;
Mancia, G ;
Natali, A ;
Oliver, JJ ;
Pessina, AC ;
Rizzoni, D ;
Rossi, GP ;
Salvetti, A ;
Spieker, LE ;
Taddei, S ;
Webb, DJ .
JOURNAL OF HYPERTENSION, 2005, 23 (02) :233-246
[4]  
Dababneh A, 1998, J RHEUMATOL, V25, P2140
[5]   Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension [J].
Deanfield, J ;
Donald, A ;
Ferri, C ;
Giannattasio, C ;
Halcox, J ;
Halligan, S ;
Lerman, A ;
Mancia, G ;
Oliver, JJ ;
Pessina, AC ;
Rizzoni, D ;
Rossi, GP ;
Salvetti, A ;
Schiffrin, EL ;
Taddei, S ;
Webb, DJ .
JOURNAL OF HYPERTENSION, 2005, 23 (01) :7-17
[6]  
del Rincón I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO
[7]  
2-#
[8]  
Dessein PH, 2005, J RHEUMATOL, V32, P435
[9]  
Gladman DD, 1998, ARTHRITIS RHEUM-US, V41, P1103, DOI 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO
[10]  
2-N